QDEL

SEC source: 0000899243-22-020512 · doc4.xml · derivative · entry 5

Michael Edward L. · CIK 0001391823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106

Underlying: Common Stock · 106 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F3 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020512 · doc4.xml · derivative · entry 4

Michael Edward L. · CIK 0001391823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 356

Underlying: Common Stock · 356 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F3 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020512 · doc4.xml · derivative · entry 3

Michael Edward L. · CIK 0001391823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 341

Underlying: Common Stock · 341 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F3 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020512 · doc4.xml · derivative · entry 2

Michael Edward L. · CIK 0001391823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,137

Underlying: Common Stock · 1,137 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F3 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020512 · doc4.xml · nonDerivative · entry 1

Michael Edward L. · CIK 0001391823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,098

F1 · kind: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.

F1 · price: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.

SEC source: 0000899243-22-020510 · doc4.xml · derivative · entry 12

Kroll Werner · CIK 0001609320 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,256

Underlying: Common Stock · 7,256 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F6 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F14 · derivative.exercise_date: 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026.

F14 · derivative.expiration_date: 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026.

SEC source: 0000899243-22-020510 · doc4.xml · derivative · entry 11

Kroll Werner · CIK 0001609320 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,642

Underlying: Common Stock · 10,642 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F6 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F13 · derivative.exercise_date: 3,547 shares will vest on each of January 31, 2023 and January 31, 2024; 3,548 shares will vest on January 31, 2025.

F13 · derivative.expiration_date: 3,547 shares will vest on each of January 31, 2023 and January 31, 2024; 3,548 shares will vest on January 31, 2025.

SEC source: 0000899243-22-020510 · doc4.xml · derivative · entry 10

Kroll Werner · CIK 0001609320 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,510

Underlying: Common Stock · 3,510 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F6 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F12 · derivative.exercise_date: 3,510 shares will vest in equal installments on July 28, 2022, July 28, 2023 and July 28, 2024.

F12 · derivative.expiration_date: 3,510 shares will vest in equal installments on July 28, 2022, July 28, 2023 and July 28, 2024.

SEC source: 0000899243-22-020510 · doc4.xml · derivative · entry 9

Kroll Werner · CIK 0001609320 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,625

Underlying: Common Stock · 2,625 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F6 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F11 · derivative.exercise_date: 1,312 shares will vest on February 1, 2023; and 1,313 shares will vest on February 1, 2024.

F11 · derivative.expiration_date: 1,312 shares will vest on February 1, 2023; and 1,313 shares will vest on February 1, 2024.

SEC source: 0000899243-22-020510 · doc4.xml · derivative · entry 8

Kroll Werner · CIK 0001609320 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,962

Underlying: Common Stock · 1,962 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F6 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F10 · derivative.exercise_date: 1,962 shares will vest in equal installments on July 1, 2022 and July 1, 2023.

F10 · derivative.expiration_date: 1,962 shares will vest in equal installments on July 1, 2022 and July 1, 2023.

SEC source: 0000899243-22-020510 · doc4.xml · derivative · entry 7

Kroll Werner · CIK 0001609320 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,268

Underlying: Common Stock · 4,268 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F6 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F9 · derivative.exercise_date: 4,268 shares will vest on February 4, 2023.

F9 · derivative.expiration_date: 4,268 shares will vest on February 4, 2023.

SEC source: 0000899243-22-020510 · doc4.xml · derivative · entry 6

Kroll Werner · CIK 0001609320 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 823

Underlying: Common Stock · 823 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F6 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F8 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

F8 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020510 · doc4.xml · derivative · entry 5

Kroll Werner · CIK 0001609320 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,743

Underlying: Common Stock · 2,743 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F6 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F8 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

F8 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020510 · doc4.xml · derivative · entry 4

Kroll Werner · CIK 0001609320 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,925

Underlying: Common Stock · 3,925 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F6 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F7 · derivative.exercise_date: 3,925 shares will vest on February 4, 2023.

F7 · derivative.expiration_date: 3,925 shares will vest on February 4, 2023.

SEC source: 0000899243-22-020510 · doc4.xml · derivative · entry 3

Kroll Werner · CIK 0001609320 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,924

Underlying: Common Stock · 3,924 shares

Expires 2029-02-04

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F4 · derivative.exercise_date: 5,888 shares are vested in full; 1,962 shares will vest on February 4, 2023.

SEC source: 0000899243-22-020510 · doc4.xml · derivative · entry 2

Kroll Werner · CIK 0001609320 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,303

Underlying: Common Stock · 2,303 shares

Expires 2028-01-16

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F3 · derivative.exercise_date: Vested in full.

SEC source: 0000899243-22-020510 · doc4.xml · nonDerivative · entry 1

Kroll Werner · CIK 0001609320 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,762

F1 · kind: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.

F1 · price: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.

SEC source: 0000899243-22-020491 · doc4.xml · derivative · entry 13

Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 204

Underlying: Common Stock · 204 shares

Expires not disclosed

F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F15 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

F16 · derivative.exercise_date: 204 shares will vest on January 31, 2023.

F15 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

F16 · derivative.expiration_date: 204 shares will vest on January 31, 2023.

SEC source: 0000899243-22-020491 · doc4.xml · derivative · entry 12

Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,020

Underlying: Common Stock · 1,020 shares

Expires not disclosed

F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F15 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

F15 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020491 · doc4.xml · derivative · entry 11

Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,256

Underlying: Common Stock · 7,256 shares

Expires not disclosed

F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F14 · derivative.exercise_date: 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026.

F14 · derivative.expiration_date: 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026.

SEC source: 0000899243-22-020491 · doc4.xml · derivative · entry 10

Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,439

Underlying: Common Stock · 6,439 shares

Expires not disclosed

F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F13 · derivative.exercise_date: 1,609 shares will vest on January 31, 2023; the remaining 4,830 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026.

F13 · derivative.expiration_date: 1,609 shares will vest on January 31, 2023; the remaining 4,830 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026.

SEC source: 0000899243-22-020491 · doc4.xml · derivative · entry 9

Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,910

Underlying: Common Stock · 11,910 shares

Expires not disclosed

F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F12 · derivative.exercise_date: 11,910 shares will vest in equal installments on November 8, 2022, November 8, 2023 and November 8, 2024.

F12 · derivative.expiration_date: 11,910 shares will vest in equal installments on November 8, 2022, November 8, 2023 and November 8, 2024.

SEC source: 0000899243-22-020491 · doc4.xml · derivative · entry 8

Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,559

Underlying: Common Stock · 1,559 shares

Expires not disclosed

F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F11 · derivative.exercise_date: 389 shares will vest on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025.

F11 · derivative.expiration_date: 389 shares will vest on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025.

SEC source: 0000899243-22-020491 · doc4.xml · derivative · entry 7

Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,260

Underlying: Common Stock · 1,260 shares

Expires not disclosed

F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F10 · derivative.exercise_date: 1,260 shares will vest in equal installments on May 25, 2023, May 25, 2024 and May 25, 2025.

F10 · derivative.expiration_date: 1,260 shares will vest in equal installments on May 25, 2023, May 25, 2024 and May 25, 2025.

SEC source: 0000899243-22-020491 · doc4.xml · derivative · entry 6

Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,420

Underlying: Common Stock · 1,420 shares

Expires not disclosed

F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F9 · derivative.exercise_date: 473 shares will vest on each of February 1, 2023 and February 1, 2024; 474 shares will vest on February 1, 2025.

F9 · derivative.expiration_date: 473 shares will vest on each of February 1, 2023 and February 1, 2024; 474 shares will vest on February 1, 2025.

SEC source: 0000899243-22-020491 · doc4.xml · derivative · entry 5

Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 714

Underlying: Common Stock · 714 shares

Expires not disclosed

F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F8 · derivative.exercise_date: 714 shares will vest in equal installments on December 1, 2022, December 1, 2023 and December 1, 2024.

F8 · derivative.expiration_date: 714 shares will vest in equal installments on December 1, 2022, December 1, 2023 and December 1, 2024.

SEC source: 0000899243-22-020491 · doc4.xml · derivative · entry 4

Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,438

Underlying: Common Stock · 6,438 shares

Expires 2032-01-31

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F5 · derivative.exercise_date: 1,609 shares will vest on each of January 31, 2023 and January 31, 2024; 1,610 shares will vest on each of January 31, 2025 and January 31, 2026.

SEC source: 0000899243-22-020491 · doc4.xml · derivative · entry 3

Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,892

Underlying: Common Stock · 1,892 shares

Expires 2031-02-01

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F4 · derivative.exercise_date: 473 shares are vested in full; the remaining 1,419 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025.

SEC source: 0000899243-22-020491 · doc4.xml · derivative · entry 2

Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,105

Underlying: Common Stock · 2,105 shares

Expires 2030-12-01

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F3 · derivative.exercise_date: 1,052 shares will vest on December 1, 2022; 526 shares will vest on December 1, 2023; and 527 shares will vest on December 1, 2024.

SEC source: 0000899243-22-020491 · doc4.xml · nonDerivative · entry 1

Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 708

F1 · kind: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.

F1 · price: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.

SEC source: 0000899243-22-020487 · doc4.xml · derivative · entry 3

Iskra Michael S. · CIK 0001839432 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,825

Underlying: Common Stock · 15,825 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F5 · kind: Pursuant to the Business Combination Agreement, each Ortho restricted stock unit was converted into a restricted stock unit representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions), except as adjusted by the Business Combination Agreement.

F6 · derivative.exercise_date: 15,825 shares will vest on April 1, 2023.

F6 · derivative.expiration_date: 15,825 shares will vest on April 1, 2023.

SEC source: 0000899243-22-020487 · doc4.xml · derivative · entry 2

Iskra Michael S. · CIK 0001839432 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,809

Underlying: Common Stock · 16,809 shares

Expires 2024-05-27

F1 · kind: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation, Ortho Clinical Diagnostics Holdings plc ("Ortho"), QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each Ortho stock option was converted into a Stock Option to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions), except as adjusted by the Business Combination Agreement.

F3 · derivative.exercise_date: 9,804 shares are vested in full; 7,005 shares will vest on July 1, 2022.

SEC source: 0000899243-22-020487 · doc4.xml · derivative · entry 1

Iskra Michael S. · CIK 0001839432 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,020

Underlying: Common Stock · 22,020 shares

Expires 2025-12-21

F1 · kind: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation, Ortho Clinical Diagnostics Holdings plc ("Ortho"), QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each Ortho stock option was converted into a Stock Option to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions), except as adjusted by the Business Combination Agreement.

F2 · derivative.exercise_date: Vested in full.

SEC source: 0000899243-22-020489 · doc4.xml · nonDerivative · entry 1

Wilkins Joseph D Jr. · CIK 0001848760 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,913

F1 · kind: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.

F1 · price: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.

SEC source: 0001209191-22-043762 · doc4a.xml · nonDerivative · entry 1

Smith Christopher M · CIK 0001436707 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,554

F1 · date: The Form 4 originally filed on June 1, 2022 is being amended to correct the vesting schedule with respect to 29,418 restricted stock awards held by the reporting person.

F2 · kind: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation, Ortho Clinical Diagnostics Holdings plc ("Ortho"), QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc., and Orca Holdco 2, Inc., each ordinary share of Ortho beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for (i) 0.1055 shares of common stock of QuidelOrtho and (ii) $7.14 in cash.

F2 · price: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation, Ortho Clinical Diagnostics Holdings plc ("Ortho"), QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc., and Orca Holdco 2, Inc., each ordinary share of Ortho beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for (i) 0.1055 shares of common stock of QuidelOrtho and (ii) $7.14 in cash.

F3 · balance_after: Includes 29,418 restricted stock awards, of which 4,203 shares vested on July 28, 2022, 16,811 shares will vest on September 9, 2022, 4,201 shares will vest on February 28, 2023 and 4,203 shares will vest on May 27, 2023.

SEC source: 0000950170-24-016352 · ownership.xml · nonDerivative · entry 1

Brandy Louise · CIK 0001978061 · SVP, Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,427

F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4.

F2 · balance_after: The amount of shares beneficially owned following this transaction includes an additional 76 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan.

SEC source: 0000950170-24-064156 · ownership.xml · nonDerivative · entry 1

POLAN MARY LAKE PH D · CIK 0001187716 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,740